-
PHIO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Phio Pharmaceuticals (PHIO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.39 mm | 5.39 mm | 5.39 mm | 5.39 mm | 5.39 mm | 5.39 mm |
Cash burn (monthly) | (no burn) | 255.58 k | 530.00 k | 634.33 k | 651.00 k | 675.92 k |
Cash used (since last report) | n/a | 1.12 mm | 2.33 mm | 2.79 mm | 2.86 mm | 2.97 mm |
Cash remaining | n/a | 4.27 mm | 3.06 mm | 2.60 mm | 2.53 mm | 2.42 mm |
Runway (months of cash) | n/a | 16.7 | 5.8 | 4.1 | 3.9 | 3.6 |
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 2 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 20.35 mm |
Total shares | 1.08 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Intracoastal Capital | 811.83 k | $0.00 |
CVI Investments | 228.90 k | $616.00 k |
Geode Capital Management | 28.14 k | $19.66 mm |
Cambridge Investment Research Advisors | 14.23 k | $10.00 k |
Activest Wealth Management | 83.00 | $57.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Sep 24 | Robert L Ferrara | Common stock, $0.0001 par value | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 10,000 |
11 Sep 24 | Patricia A Bradford | Common Stock, $0.0001 par value | Grant | Acquire A | No | No | 0 | 8,000 | 0.00 | 8,000 |
11 Sep 24 | Curtis Lockshin | Common Stock, $0.0001 par value | Grant | Acquire A | No | No | 0 | 2,000 | 0.00 | 2,000 |
11 Sep 24 | Robert M. Infarinato | Common Stock, $0.0001 Par Value | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 11,000 |
11 Sep 24 | Jonathan E Freeman | Common Stock, $0.0001 par value | Grant | Acquire A | No | No | 0 | 1,000 | 0.00 | 1,000 |